pyrazines has been researched along with mitomycin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
O'Dwyer, PJ; Yao, KS | 1 |
Hall, EJ; Hei, TK; Liu, SX | 1 |
Cassidy, J; Hochster, H | 1 |
1 review(s) available for pyrazines and mitomycin
Article | Year |
---|---|
New oxaliplatin-based combinations in the treatment of colorectal cancer.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Boronic Acids; Bortezomib; Camptothecin; Capecitabine; Cetuximab; Colorectal Neoplasms; Deoxycytidine; Fluorouracil; Gefitinib; Humans; Irinotecan; Mitomycin; Organoplatinum Compounds; Oxaliplatin; Pyrazines; Quinazolines; Thiophenes | 2003 |
2 other study(ies) available for pyrazines and mitomycin
Article | Year |
---|---|
Involvement of NF-kappa B in the induction of NAD(P)H:quinone oxidoreductase (DT-diaphorase) by hypoxia, oltipraz and mitomycin C.
Topics: Anticarcinogenic Agents; Base Sequence; Cell Hypoxia; Enzyme Induction; Humans; Mitomycin; Molecular Sequence Data; NAD(P)H Dehydrogenase (Quinone); NF-kappa B; Protein Binding; Pyrazines; Signal Transduction; Thiones; Thiophenes; Tumor Cells, Cultured | 1995 |
Oncogenic potential of bifunctional bioreductive drugs.
Topics: Animals; Antineoplastic Agents; Aziridines; Cell Survival; Cell Transformation, Neoplastic; Indolequinones; Indoles; Mice; Mice, Inbred C3H; Mitomycin; Oxidation-Reduction; Pyrazines; Structure-Activity Relationship | 1996 |